{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:26:27Z","timestamp":1792661187994,"version":"4.5.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Programmed death-1 (PD-1)\u2013PD-1 ligand (PD-L) signaling system is involved in the functional impairment of T cells such as in chronic viral infection or tumor immune evasion. We examined PD-L expression in lymphoid cell lines and found that they were up-regulated on Hodgkin lymphoma (HL) and several T-cell lymphomas but not on B-cell lymphomas. PD-L expression was also demonstrated in primary Hodgkin\/Reed-Sternberg (H\/RS) cells. On the other hand, PD-1 was elevated markedly in tumor-infiltrating T cells of HL, and was high in the peripheral T cells of HL patients as well. Blockade of the PD-1 signaling pathway inhibited SHP-2 phosphorylation and restored the IFN-\u03b3\u2013producing function of HL-infiltrating T cells. According to these results, deficient cellular immunity observed in HL patients can be explained by \u201cT-cell exhaustion,\u201d which is led by the activation of PD-1\u2013PD-L signaling pathway. Our finding provides a potentially effective immunologic strategy for the treatment of HL.<\/jats:p>","DOI":"10.1182\/blood-2007-05-085159","type":"journal-article","created":{"date-parts":[[2008,1,19]],"date-time":"2008-01-19T02:24:52Z","timestamp":1200709492000},"page":"3220-3224","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":338,"title":["PD-1\u2013PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma"],"prefix":"10.1182","volume":"111","author":[{"given":"Ryo","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Kitawaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Hishizawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Tashima","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Ohmori","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Kyoto University Hospital, Shogoin Kawahara-cho, Sakyo-ku, Kyoto;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kurata","sequence":"additional","affiliation":[{"name":"Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, Minatojima-Nakamachi, Chuo-ku, Kobe; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tenri Hospital, Mishima-cho, Tenri, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111713394745400_B1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri1349","article-title":"Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.","volume":"4","author":"Chen","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"2019111713394745400_B2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection.","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"2019111713394745400_B3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"2019111713394745400_B4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med"},{"key":"2019111713394745400_B5","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1084\/jem.20061496","article-title":"PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.","volume":"203","author":"Petrovas","year":"2006","journal-title":"J Exp Med"},{"key":"2019111713394745400_B6","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade.","volume":"203","author":"Freeman","year":"2006","journal-title":"J Exp Med"},{"key":"2019111713394745400_B7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"2019111713394745400_B8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.1089.65.3","article-title":"Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.","volume":"65","author":"Hirano","year":"2005","journal-title":"Cancer Res"},{"key":"2019111713394745400_B9","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1158\/1078-0432.CCR-04-1469","article-title":"Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer","volume":"11","author":"Ohigashi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019111713394745400_B10","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1078-0432.CCR-06-2599","article-title":"PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.","volume":"13","author":"Thompson","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2019111713394745400_B11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/scbi.2000.0327","article-title":"Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas.","volume":"10","author":"Poppema","year":"2000","journal-title":"Semin Cancer Biol"},{"key":"2019111713394745400_B12","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1182\/blood-2002-08-2464","article-title":"High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease.","volume":"101","author":"Nishikori","year":"2003","journal-title":"Blood"},{"key":"2019111713394745400_B13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1349-7006.2003.tb01518.x","article-title":"Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma.","volume":"94","author":"Maesako","year":"2003","journal-title":"Cancer Sci"},{"key":"2019111713394745400_B14","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1158\/1078-0432.CCR-04-0428","article-title":"B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.","volume":"10","author":"Konishi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2019111713394745400_B15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1349-7006.2005.00078.x","article-title":"Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-\u03baB p52, which is associated with hyperphosphorylated Bcl-3.","volume":"96","author":"Nishikori","year":"2005","journal-title":"Cancer Sci"},{"key":"2019111713394745400_B16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","article-title":"Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma.","volume":"30","author":"Dorfman","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"2019111713394745400_B17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma.","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"},{"key":"2019111713394745400_B18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1158\/1078-0432.CCR-04-1869","article-title":"Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.","volume":"11","author":"Alvaro","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019111713394745400_B19","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2006-04-015164","article-title":"Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.","volume":"108","author":"Gandhi","year":"2006","journal-title":"Blood"},{"key":"2019111713394745400_B20","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.exphem.2007.01.030","article-title":"The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.","volume":"35","author":"Marshall","year":"2007","journal-title":"Exp Hematol"},{"key":"2019111713394745400_B21","doi-asserted-by":"crossref","first-page":"13134","DOI":"10.1073\/pnas.0706017104","article-title":"The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.","volume":"104","author":"Juszczynski","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713394745400_B22","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2005-08-3376","article-title":"Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.","volume":"107","author":"Yang","year":"2006","journal-title":"Blood"},{"key":"2019111713394745400_B23","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.231486598","article-title":"PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.","volume":"98","author":"Okazaki","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713394745400_B24","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2006-12-064360","article-title":"RNA fingerprints provide direct evidence for the inhibitory role of TGF\u03b2 and PD-1 on CD4+ T cells in Hodgkin lymphoma.","volume":"110","author":"Chemnitz","year":"2007","journal-title":"Blood"},{"key":"2019111713394745400_B25","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20040890","article-title":"Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.","volume":"200","author":"Bollard","year":"2004","journal-title":"J Exp Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/6\/3220\/1297301\/zh800608003220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/6\/3220\/1297301\/zh800608003220.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T22:33:35Z","timestamp":1684190015000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/6\/3220\/24137\/PD1PD1-ligand-interaction-contributes-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,15]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,3,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-05-085159","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,15]]}}}